Jasper Therapeutics Shares Decline Following Announcement of 1-for-30 Reverse Stock Split
Jasper Therapeutics (JSPR) shares experienced a significant decline of over 14% on Wednesday following the company's announcement of a 1-for-30 reverse stock split. The corporate action is scheduled to take effect on November 6, 2026. Post-split, the company expects to have approximately 1.11 million shares of common stock issued and outstanding, a substantial reduction from the current level of nearly 33.3 million shares. Such moves are often viewed by markets as attempts to increase share price or meet exchange listing requirements.
Tickers: $JSPR
Topics: equity restructuring share price volatility stock split
Read the full article at Seeking Alpha
Part of the story Jasper Therapeutics Shares Decline Following Announcement of 1-for-30 Reverse Stock Split (5 articles)